BAY 50-4798, a novel, high-affinity receptor-specific recombinant interleukin-2 analog, induces dose-dependent increases in CD25 expression and proliferation among unstimulated, human peripheral blood mononuclear cells in vitro
Lynn T. Matthews(University of Alabama at Birmingham), Irini Sereti(National Institutes of Health), H. Clifford Lane(National Institute of Allergy and Infectious Diseases), Sherita Chapman, Richard T. Davey(National Institutes of Health), Meena S. Ramchandani(Public Health – Seattle & King County)
Cited by 11
Related Papers
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
|Journal of Clinical Oncology|2014|714
Integrated Portable Genetic Analysis Microsystem for Pathogen/Infectious Disease Detection
|Analytical Chemistry|2004|283
HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases
|Nature Communications|2020|233